New Cream Offers Relief for Patients with Plaque Psoriasis
Discover tapinarof cream 1%, a novel nonsteroidal aryl hydrocarbon receptor agonist, that has emerged as a promising solution for plaque psoriasis.
Related Articles
Therapeutic Relevance of Sebum in the Pathophysiology of Acne Vulgaris
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Plaque Psoriasis Management: Evaluating Non-Steroidal Treatments and Current Data Trends
Alexa Hetzel, MS, PA-C; Andrew Mastro, MS, PA-C; TJ Chao, MPAS, PA-C, and Terry Faleye, MPAS, PA-C, explore plaque psoriasis through patient case analyses and…
Optimizing Personalized Management: Case Studies in Plaque Psoriasis Treatment
E. James Song, MD, FAAD, presents patient cases, discusses clinical practices, and provides comprehensive insights on the treatment landscape for plaque psoriasis.
Dermatology Times 2024 In Review: Aesthetic/Cosmetic Dermatology
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in aesthetic/cosmetic dermatology this year.
Dermatology Times 2024 in Review: Psoriasis
As 2023 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in psoriasis this year.
Targeted Precision Cryotherapy Treatment for Acne Lesions
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
Dermatology Times 2024 In Review: Vitiligo
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in vitiligo this year.
Derm In The News: 2024
Dermatology Times is looking back on the top dermatology news headlines from 2024.
Table of Contents page: Journal of the American Academy of Dermatology
AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features. Edited by Jennifer…
Incidence, Mortality, and Sequelae of Epidermal Necrolysis in Adults
This cohort study assesses the incidence of and compares factors associated with in-hospital and postdischarge mortality and sequelae among patients with epidermal necrolysis.
